Srkalovic G - Search Results

1

Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.

Szende B, Srkalovic G, Groot K, Lapis K, Schally AV. Szende B, et al. Among authors: srkalovic g. Cancer Res. 1990 Jun 15;50(12):3716-21. Cancer Res. 1990. PMID: 2160323

2

Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).

Bokser L, Srkalovic G, Szepeshazi K, Schally AV. Bokser L, et al. Among authors: srkalovic g. Neuroendocrinology. 1991 Aug;54(2):136-45. doi: 10.1159/000125862. Neuroendocrinology. 1991. PMID: 1662786

3

Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells.

Szende B, Srkalovic G, Timar J, Mulchahey JJ, Neill JD, Lapis K, Csikos A, Szepeshazi K, Schally AV. Szende B, et al. Among authors: srkalovic g. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4153-6. doi: 10.1073/pnas.88.10.4153. Proc Natl Acad Sci U S A. 1991. PMID: 1851995 Free PMC article.

4

Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.

Szende B, Srkalovic G, Schally AV, Lapis K, Groot K. Szende B, et al. Among authors: srkalovic g. Cancer. 1990 May 15;65(10):2279-90. doi: 10.1002/1097-0142(19900515)65:10<2279::aid-cncr2820651020>3.0.co;2-3. Cancer. 1990. PMID: 1971771

5

Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies.

Schally AV, Srkalovic G, Szende B, Redding TW, Janaky T, Juhasz A, Korkut E, Cai RZ, Szepeshazi K, Radulovic S, et al. Schally AV, et al. Among authors: srkalovic g. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1061-7. doi: 10.1016/0960-0760(90)90466-x. J Steroid Biochem Mol Biol. 1990. PMID: 1981009 Review.

6

Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma.

Srkalovic G, Wittliff JL, Schally AV. Srkalovic G, et al. Cancer Res. 1990 Mar 15;50(6):1841-6. Cancer Res. 1990. PMID: 2155060

7

Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.

Szende B, Srkalovic G, Groot K, Lapis K, Schally AV. Szende B, et al. Among authors: srkalovic g. J Natl Cancer Inst. 1990 Mar 21;82(6):513-7. doi: 10.1093/jnci/82.6.513. J Natl Cancer Inst. 1990. PMID: 2156080

8

Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV. Srkalovic G, et al. Endocrinology. 1990 Dec;127(6):3052-60. doi: 10.1210/endo-127-6-3052. Endocrinology. 1990. PMID: 2174343

9

Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma.

Srkalovic G, Szende B, Redding TW, Groot K, Schally AV. Srkalovic G, et al. Proc Soc Exp Biol Med. 1989 Dec;192(3):209-18. doi: 10.3181/00379727-192-42987. Proc Soc Exp Biol Med. 1989. PMID: 2574866

10

Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin.

Szende B, Lapis K, Redding TW, Srkalovic G, Schally AV. Szende B, et al. Among authors: srkalovic g. Breast Cancer Res Treat. 1989 Dec;14(3):307-14. doi: 10.1007/BF01806302. Breast Cancer Res Treat. 1989. PMID: 2575407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters